Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study) - Trial NCT06268522
Access comprehensive clinical trial information for NCT06268522 through Pure Global AI's free database. This phase not specified trial is sponsored by Brigham and Women's Hospital and is currently Recruiting. The study focuses on Low Back Pain. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Brigham and Women's Hospital
Timeline & Enrollment
N/A
Feb 01, 2024
Jun 01, 2024
Primary Outcome
Pain Interference,Opioid Dose
Summary
This study is a Randomized Controlled Trial exploring the effects of a Mindfulness
 interventions in reducing pain interference and opioid dose in patients with Chronic Low Back
 Pain. A total of 200 opioid-using patients with chronic pain, male and female participants
 will be enrolled, with a need for 160 completers. Patient will be randomly assigned into the
 Mindfulness-Oriented Recovery Enhancement or the Psychoeducation comparison control group.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06268522
Non-Device Trial